Physiomics warns on profit as pandemic bites

Mon, 10th May 2021

Cancer treatment consultancy Physiomics warned it would post a worse-than-expected full-year loss. Physiomics said net losses for the year through June were likely to be in the range of £0.17 million-to-£0.20 million, on revenue of £0.70 million-to-£0.80 million. 'This is below market expectations and due to both Covid-related project delays and to an increased focus on longer-term value-generating activities,' it said. The company said its cash position remained 'strong', with a net asset position at 30 June estimated to be around £1.1 million, the majority in cash. At 8:48am: (LON:PYC) Physiomics PLC share price was 0p at 6.1p Story provided by

FTSE 100 Latest